S&P assigns ‘AA’ rating to Mayo Clinic’s bonds

S&P Global Ratings has assigned an “AA” rating to Rochester, Minn.-based Mayo Clinic’s $290 million of series 2016B bonds.

Advertisement

“The long-term rating on the Mayo Clinic reflects an excellent enterprise profile as one of the country’s leading health systems,” said S&P analyst Martin Arrick.

The outlook is stable. “The stable outlook reflects our view that the Mayo Clinic’s sound financial profile is sustainable over the two-year outlook period,” Mr. Arrick added.

More articles on healthcare finance:
Moody’s revises Atlantic Health System’s outlook to positive
Aprima reports double-digit revenue growth in first half of 2016
Are concerns about orphan drug spending justified?

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.